Quarterly Spotlight - Corporate Venture Capital Deal Analysis - Q3'2024

Corporate Venture Capital (CVC) deal activity continued its decline; however, funds were infused into more established businesses.

In Q3 2024, the corporate venture capital (CVC) market saw mixed results, with deal activity declining by 1.2% but capital investment rising by 3.2% to $25.8 Bn across 1,056 deals. The market was dominated by North America and Asia which accounted for 86% of total investments. North America led with $15.9 Bn, followed by Asia at $6.3 Bn.

CVC investments were primarily directed toward software, biotech, and semiconductors, which together captured 60% of the total capital. Later-stage investments (Rounds 3 and 4) made up 38% of deals, while early-stage funding (Round 1) saw a 78% year-over-year increase, signaling a growing interest in established startups. Major CVC players like Alphabet, Sumitomo Mitsui, and Salesforce were highly active.

This edition of the Quarterly Insights on CVC Deal Analysis provides an overview of global CVC investment activity, highlighting key sectors, active CVC funds, and significant deals completed during the quarter.